Tag: baxdela

October 29, 2018

Melinta Therapeutics Releases Positive Trial Results

The positive results from this trial set the company up to file a supplemental new drug application in the first...
October 29, 2018

Melinta Therapeutics Announces Positive Top-Line Results in Phase III Trial of Baxdela

Melinta Therapeutics (NASDAQ:MLNT), a commercial-stage company discovering, developing and commercializing novel antibiotics to treat serious bacterial infections, today announced positive...